Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer

Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer

Generic quality of life (QoL) is an important issue in decision making related to the primary treatment of localized prostate cancer (PC). This study assessed the dynamic changes of QoL in patients with localized PC under different treatment modalities. From 2013 to 2018, we prospectively assessed Q...

Full description

Bibliographic Details
Main Authors:	Yao-Lin Kao, Chien-Hui Ou, Sheng-Hsiang Lin, Sheng-Mao Chang, Jung-Der Wang, Yuh-Shyan Tsai
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Journal of Clinical Medicine
Subjects:	prostate cancer quality of life prostatectomy radiotherapy active surveillance
Online Access:	https://www.mdpi.com/2077-0383/10/1/158

Similar Items

Association between body mass index and localized prostate cancer management and disease‐specific quality of life
by: Nathan L. Samora, et al.
Published: (2023-03-01)

Early stage prostate cancer: biochemical recurrence after treatment
by: Danielle A. Zanatta, et al.
Published: (2014-04-01)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
by: Saum Ghodoussipour, et al.

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
by: Leonardo O. Reis, et al.

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
by: Gustavo Arruda Viani, et al.

Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States
by: Jang Hee Han, et al.
Published: (2023-10-01)

The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
by: Jongchan Kim, et al.
Published: (2017-09-01)

Radical exenteration surgery is curative in locally advance mucinous prostatic adenocarcinoma involving bladder and rectum
by: Vincent S W Koo, et al.
Published: (2010-06-01)

A nomogram model for determining optimal patients for local therapy in metastatic prostate cancer: a SEER database-based study
by: Lin Yang, et al.
Published: (2023-01-01)

Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer
by: Won Sik Ham, et al.
Published: (2024-03-01)

Preclinical evaluation of intraoperative low-energy photon radiotherapy using sphericalapplicators in locally advanced prostate cancer
by: François eBuge, et al.
Published: (2015-09-01)

Evaluation of various active surveillance protocols in prostate cancer
by: Kayhan Yılmaz, et al.
Published: (2014-06-01)

Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
by: Berdine L. Heesterman, et al.
Published: (2023-05-01)

Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer
by: Daniel Seabra, et al.
Published: (2009-02-01)

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
by: Katz Alan, et al.
Published: (2012-11-01)

Evaluation of the changing landscape of prostate cancer diagnosis and management from 2005 to 2016
by: Kirsten R. Carlaw, et al.
Published: (2017-12-01)

Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
by: Young Suk Kwon, et al.
Published: (2021-06-01)

Does a previous prostate biopsy-related acute bacterial prostatitis affect the results of radical prostatectomy?
by: Hakan Türk, et al.

Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance
by: Seol Ho Choo, et al.
Published: (2014-06-01)

Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer
by: Hung-Jen Shih, et al.
Published: (2021-11-01)

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
by: Zhipeng Wang, et al.
Published: (2020-02-01)

Pre-radiotherapy PSA Level as a Predictor for Biochemical Control in Prostate Cancer Patients Receiving Radiotherapy after Radical Prostatectomy
by: Din-Li Tsan, et al.
Published: (2013-04-01)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
by: Thiago N. Valette, et al.
Published: (2015-06-01)

Association between Fecal Incontinence and Lower Urinary Tract Symptoms and their Impact on the Quality of Life of Patients with Prostate Cancer
by: Natália Burgos Freire Azevedo, et al.
Published: (2022-03-01)

The role of rectal sparing devices in post-prostatectomy radiotherapy: a review article
by: Arezoo Mehrabian, et al.
Published: (2023-03-01)

The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis
by: Xu Cheng, et al.
Published: (2020-01-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
by: Fundagul Andic, et al.
Published: (2019-01-01)

Comparative analysis of radical prostatectomy techniques using perineal or suprapubic approach in the treatment of localized prostate cancer
by: Gelbert Luiz Chamon do Carmo Amorim, et al.
Published: (2010-06-01)

Comparative analysis of radical prostatectomy techniques using perineal or suprapubic approach in the treatment of localized prostate cancer
by: Gelbert Luiz Chamon do Carmo Amorim, et al.
Published: (2010-06-01)

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review
by: Léonard Depotte, et al.
Published: (2023-01-01)

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
by: Vincent Q. Trinh, et al.
Published: (2019-04-01)

Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
by: Alessandro Sciarra, et al.
Published: (2016-11-01)

Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
by: Francesco A. Mistretta, et al.
Published: (2022-05-01)

Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions
by: Benjamin A. Greenberger, et al.
Published: (2019-11-01)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
by: Ann-Kathrin Oehus, et al.
Published: (2020-04-01)

The Clinical Applications of Tissue Biomarkers in Prostate Cancer
by: Peter Lonergan, Samuel Washington, Maxwell Meng, Renu Eapen
Published: (2020-10-01)

Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
by: Rasmus Nilsson, et al.
Published: (2021-03-01)

Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No
by: Benjamin T. Ristau, et al.

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
by: Yoshiro Sakamoto, et al.
Published: (2014-09-01)